Do You Qualify?

Please fill out this form and provide us with the type of illness you experienced. We will reach out to you to discuss your eligibility to receive compensation.

UTERINE CANCER RISK

HAIR RELAXER LAWSUITS

If you suffered uterine cancer after using hair relaxer or straightener products, you may be entitled to compensation. Submit the form for a free, no-obligation case review.

According to a recent study, Consumers who use hair straightening or relaxing products have an alarmingly high incidence of uterine cancer.

According to a study in the Journal of the National Cancer Institute, uterine cancer is more likely to occur in people who use chemicals to straighten or relax their hair. According to the study, women of color, particularly Black women, who frequently use these products to style their naturally curly or wavy hair had a higher risk of being diagnosed with cancer. Numerous ladies who had medical problems after using these goods have sued various manufacturers for hair straightener cancer.

Chemicals are combined in relaxers and straighteners to weaken each hair’s structure and render it more malleable and soft. Many times a year, those who want a smoother style utilize these items to keep the style in place. Unfortunately, use of relaxers and straighteners on a regular basis for a long period of time has been associated to an elevated risk of uterine cancer.

You might be qualified to file a product liability case against the maker of the hair straightening or relaxing products you used if medical professionals found that you or a loved one had uterine cancer and you had previously used such products.

Recent developments in the Hair Relaxer Lawsuits. Key Points:

1️⃣ Master Complaint lodged to streamline litigation.
2️⃣ Boston University study links hair relaxers to decreased fertility, particularly among Black, Hispanic, and mixed-race individuals.
3️⃣ Defendants propose a bifurcated discovery process, meeting strong objections from plaintiffs.
4️⃣ MDL grows with 25 new cases, total now stands at 149, with more expected.